Systemic Complications Secondary to Chronic Liver Disease

© 2023. The Author(s)..

The systemic sequelae of chronic liver disease (CLD) may be due to portal hypertension and shunting, malnutrition, and/or a low grade inflammatory state. This article will focus on the consequences of chronic liver disease affecting extrahepatic organs. Portal hypertension underlies many systemic complications of CLD. Aside from varices and ascites, portal hypertension may cause both hepatopulmonary syndrome and portopulmonary hypertension leading to respiratory compromise. Cardiomyopathy may also occur secondary to end stage liver disease. Hepatorenal syndrome is also well recognised and hepatic encephalopathy is a consequence of the effect of liver dysfunction on the brain. Compromise of the immune system is well described in end-stage liver disease leading to sepsis and its consequences. Bony disease including osteoporosis and hepatic arthropathy may both be seen in children with CLD. CLD may be asymptomatic initially but then complications may present as the disease progresses. Furthermore, systemic effects of end stage liver disease may complicate liver transplant. These complications often present insidiously or at the time of acute decompensation. Thus, it is important that healthcare providers are vigilant when caring for children with CLD. This article outlines the secondary complications of CLD with an overview of the definition and diagnosis, pathophysiology, management and prognosis of each.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:91

Enthalten in:

Indian journal of pediatrics - 91(2024), 3 vom: 02. Feb., Seite 286-293

Sprache:

Englisch

Beteiligte Personen:

Mannion, Rory [VerfasserIn]
Fitzpatrick, Emer [VerfasserIn]

Links:

Volltext

Themen:

Cirrhotic cardiomyopathy
Complications
Hepatic encephalopathy
Hepatopulmonary syndrome
Hepatorenal syndrome
Journal Article
Malnutrition
Pediatric liver disease
Portopulmonary syndrome
Review

Anmerkungen:

Date Completed 15.02.2024

Date Revised 17.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s12098-023-04694-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM359409423